GSK PLC-SPON ADR (GSK) Stock Income Statement
NYSE:GSK - New York Stock Exchange, Inc. - US37733W2044 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 31.53B | 31.38B | 30.33B | 29.32B | 24.70B | |||
| Minority Interest Expense | -489.00M | -376.00M | -380.00M | -665.00M | -711.00M | |||
| Cost Of Goods | 8.83B | 8.82B | 8.36B | 8.47B | 8.01B | |||
| Gross Profit | 22.70B | 22.56B | 21.96B | 20.86B | 16.69B | |||
| Operating Expenses | 14.83B | 14.42B | 13.66B | 12.46B | 10.94B | |||
| Research and Development | 6.04B | 6.02B | 5.75B | 5.06B | 4.53B | |||
| Selling, General, and Administrative Expenses | 9.05B | 8.97B | 9.03B | 8.13B | 6.75B | |||
| Operating Income | 7.87B | 8.14B | 8.30B | 8.39B | 5.75B | |||
| Interest Income/Expense | -523.00M | -2.54B | -1.29B | -1.44B | -2.36B | |||
| Other Income/Expense | N/A | 218.00M | -48.00M | -799.00M | 561.00M | |||
| Non Recurring Items | -3.12B | -2.34B | -897.00M | -529.00M | -355.00M | |||
| Income Before Taxes | 4.23B | 3.48B | 6.06B | 5.63B | 3.60B | |||
| Income Tax | 588.00M | 526.00M | 756.00M | 707.00M | 83.00M | |||
| Net Income | 3.15B | 2.58B | 4.93B | 14.96B | 4.38B | |||
| EBITDA | 11.10B | 10.69B | 10.60B | 10.54B | 8.13B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.56 | 1.27 | 2.45 | 7.47 | 2.20 | |||
| Non GAAP EPS | 3.29 | 3.25 | 3.17 | 3.02 | 2.89 | |||
| Statistics | ||||||||
| Gross Profit Margin | 72.01% | 71.90% | 72.42% | 71.13% | 67.58% | |||
| Profit Margin | 10.00% | 8.21% | 16.25% | 51.00% | 17.76% | |||
| Operating Profit Margin | 24.96% | 25.93% | 27.38% | 28.63% | 23.28% | |||
All data in GBP